Leading global medtech provider Teleflex is on track to acquire bariatric surgery solutions company Standard Bariatrics, which has made a name for itself with an inventive, market-leading powered stapling technology. Teleflex will flex its deep pockets to the tune of $170 million in an upfront cash payment, and an additional consideration of up to $130 million is on the table given that particular commercial milestones are met. The companies expect the deal to close in the early days of the fourth quarter of 2022.
“Teleflex’s strategy is to invest in innovative products and technologies that can meaningfully enhance clinical efficacy, patient safety and comfort, reduce complications, and lower the overall cost of care,” said Liam Kelly, the company’s Chairman, President, and Chief Executive Officer. “The acquisition of Standard Bariatrics adds an exciting and differentiated product serving the large and growing sleeve gastrectomy market, which we estimate to be approximately 120,000 procedures annually in the U.S.”
Standard Bariatrics’ flagship offering, the Titan SGS, has filled a gap in sleeve gastrectomy. Leveraging the longest continuous staple cutline of 23 centimeters, this pioneering stapler enables improved outcomes by delivering more consistent and symmetrical sleeve pouch anatomy. Though the anatomy of each and every patient differs wildly, the Titan SGS can produce stellar results in accurate staple placement in a single firing. Additionally, its design allows it to create a more stable staple line with a greatly reduced risk of leakage.